Universal Ibogaine Provides Corporate Update

Core Insights - Universal Ibogaine Inc. has temporarily closed its Kelburn Recovery Centre as part of a restructuring process aimed at exploring financing options, including potential sale or leasing of the property [1][2] - The company remains focused on its primary mission to obtain approval for ibogaine use through a planned clinical trial targeting opioid use disorder, with intentions to expand treatment protocols globally [2][3] Company Overview - Universal Ibogaine Inc. is a life sciences company dedicated to transforming addiction treatment using medicalized ibogaine, with a focus on opioid use disorder [3] - The company aims to revolutionize addiction treatment and improve the lives of individuals and families affected by addiction through planned clinical trials and future licensing agreements [3]